About this Journal Submit a Manuscript Table of Contents
Ulcers
Volume 2011 (2011), Article ID 282507, 7 pages
http://dx.doi.org/10.1155/2011/282507
Review Article

Cytomegalovirus Reactivation in Ulcerative Colitis Patients

1Department of Medicine, Cedars Sinai Medical Center, Los Angeles, CA 90048, USA
2Department of Gastroenterology, The Second Hospital of Hebei Medical University, Shijianzuang, Hebei 05000, China
3Inflammatory Bowel and Immunobiology Research Institute, Cedars-Sinai Medical Center, Davis Building, Room 4066, Los Angeles, CA 90048, USA

Received 14 August 2010; Accepted 15 November 2010

Academic Editor: T. Arakawa

Copyright © 2011 Minh Nguyen et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. G. H. Taylor, “Cytomegalovirus,” American Family Physician, vol. 67, no. 3, pp. 519–526, 2003. View at Scopus
  2. D. G. Begos, R. Rappaport, and D. Jain, “Cytomegalovirus infection masquerading as an ulcerative colitis flare- up: case report and review of the literature,” Yale Journal of Biology and Medicine, vol. 69, no. 4, pp. 323–328, 1997. View at Scopus
  3. E. Dimitroulia, N. Spanakis, A. E. Konstantinidou, N. J. Legakis, and A. Tsakris, “Frequent detection of cytomegalovirus in the intestine of patients with inflammatory bowel disease,” Inflammatory Bowel Diseases, vol. 12, no. 9, pp. 879–884, 2006. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  4. P. J. Hamlin, M. N. Shah, N. Scott, J. I. Wyatt, and P. D. Howdle, “Systemic cytomegalovirus infection complicating ulcerative colitis: a case report and review of the literature,” Postgraduate Medical Journal, vol. 80, no. 942, pp. 233–235, 2004. View at Publisher · View at Google Scholar · View at Scopus
  5. W. J. Britt and C. A. Alford, “Cytomegalovirus,” Virology, vol. 2, no. 3, pp. 2493–2523, 1996.
  6. C. Soderberg-Naucler, “Human cytomegalovirus persists in its host and attacks and avoids elimination by the immune system,” Critical Reviews in Immunology, vol. 26, no. 3, pp. 231–263, 2006. View at Scopus
  7. C. Soderberg-Naucler, K. N. Fish, and J. A. Nelson, “Reactivation of latent human cytomegalovirus by allogeneic stimulation of blood cells from healthy donors,” Cell, vol. 91, no. 1, pp. 119–126, 1997. View at Publisher · View at Google Scholar · View at Scopus
  8. C. Soderberg-Naucler, K. N. Fish, and J. A. Nelson, “Interferon-γ and tumor necrosis factor-α specifically induce formation of cytomegalovirus-permissive monocyte-derived macrophages that are refractory to the antiviral activity of these cytokines,” Journal of Clinical Investigation, vol. 100, no. 12, pp. 3154–3163, 1997. View at Scopus
  9. E. Domenech, R. Vega, I. Ojanguren, et al., “Cytomegalovirus infection in ulcerative colitis: a prospective, comparative study on prevalence and diagnostic strategy,” Inflammatory Bowel Diseases, vol. 14, no. 10, pp. 1373–1379, 2008. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  10. N. Kambham, R. Vij, C. A. Cartwright, and T. Longacre, “Cytomegalovirus infection in steroidrefractory ulcerative colitis: a case-control study,” American Journal of Surgical Pathology, vol. 28, no. 3, pp. 365–373, 2004. View at Publisher · View at Google Scholar · View at Scopus
  11. R. Osaki, A. Andoh, T. Tsujikawa et al., “Acute cytomegalovirus infection superimposed on corticosteroid-naive ulcerative colitis,” Internal Medicine, vol. 47, no. 14, pp. 1341–1344, 2008. View at Publisher · View at Google Scholar · View at Scopus
  12. P. Pfau, M. L. Kochman, E. E. Furth, and G. R. Lichtenstein, “Cytomegalovirus colitis complicating ulcerative colitis in the steroid-naive patient,” American Journal of Gastroenterology, vol. 96, no. 3, pp. 895–899, 2001. View at Publisher · View at Google Scholar · View at Scopus
  13. C. Rachima, E. Maoz, S. Apter, et al., “Cytomegalovirus infection associated with ulcerative colitis in immunocompetent individuals,” Postgraduate Medical Journal, vol. 74, no. 874, pp. 486–489, 1998. View at Scopus
  14. K. L. Streetz, T. Buhr, H. Wedemeyer et al., “Acute CMV-colitis in a patient with a history of ulcerative colitis,” Scandinavian Journal of Gastroenterology, vol. 38, no. 1, pp. 119–122, 2003. View at Scopus
  15. Y. Takahashi and T. Tange, “Prevalence of cytomegalovirus infection in inflammatory bowel disease patients,” Diseases of the Colon and Rectum, vol. 47, no. 5, pp. 722–726, 2004. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  16. K. A. Papadakis, J. K. Tung, S. W. Binder et al., “Outcome of cytomegalovirus infections in patients with inflammatory bowel disease,” American Journal of Gastroenterology, vol. 96, no. 7, pp. 2137–2142, 2001. View at Publisher · View at Google Scholar · View at Scopus
  17. R. Vega, X. Bertran, M. Menacho et al., “Cytomegalovirus infection in patients with inflammatory bowel disease,” American Journal of Gastroenterology, vol. 94, no. 4, pp. 1053–1056, 1999. View at Publisher · View at Google Scholar · View at Scopus
  18. V. C. Mariguela, S. G. F. Chacha, A. D. A. Cunha, L. E. D. A. Troncon, S. Zucoloto, and L. T. M. Figueiredo, “Cytomegalovirus in colorectal cancer and idiopathic ulcerative colitis,” Revista do Instituto de Medicina Tropical de Sao Paulo, vol. 50, no. 2, pp. 83–87, 2008. View at Publisher · View at Google Scholar · View at Scopus
  19. A. Kuwabara, H. Okamoto, T. Suda, Y. Ajioka, and K. Hatakeyama, “Clinicopathologic characteristics of clinically relevant cytomegalovirus infection in inflammatory bowel disease,” Journal of Gastroenterology, vol. 42, no. 10, pp. 823–829, 2007. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  20. M. Minami, M. Ohta, T. Ohkura et al., “Cytomegalovirus infection in severe ulcerative colitis patients undergoing continuous intravenous cyclosporine treatment in Japan,” World Journal of Gastroenterology, vol. 13, no. 5, pp. 754–760, 2007. View at Scopus
  21. G. Maconi, E. Colombo, P. Zerbi et al., “Prevalence, detection rate and outcome of cytomegalovirus infection in ulcerative colitis patients requiring colonic resection,” Digestive and Liver Disease, vol. 37, no. 6, pp. 418–423, 2005. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  22. M. Cottone, G. Pietrosi, G. Martorana et al., “Prevalence of cytomegalovirus infection in severe refractory ulcerative and Crohn's colitis,” American Journal of Gastroenterology, vol. 96, no. 3, pp. 773–775, 2001. View at Publisher · View at Google Scholar · View at Scopus
  23. V. D'Ovidio, P. Vernia, G. Gentile et al., “Cytomegalovirus infection in inflammatory bowel disease patients undergoing anti-TNFα therapy,” Journal of Clinical Virology, vol. 43, no. 2, pp. 180–183, 2008. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  24. L. C. Hookey, W. Depew, A. Boag, and S. J. Vanner, “6-Mercaptopurine and inflammatory bowel disease: hidden ground for the cytomegalovirus,” Canadian Journal of Gastroenterology, vol. 17, no. 5, pp. 319–322, 2003. View at Scopus
  25. J. Kishore, U. Ghoshal, U. C. Ghoshal et al., “Infection with cytomegalovirus in patients with inflammatory bowel disease: prevalence, clinical significance and outcome,” Journal of Medical Microbiology, vol. 53, no. 11, pp. 1155–1160, 2004. View at Publisher · View at Google Scholar · View at Scopus
  26. T. Kojima, T. Watanabe, K. Hata, M. Shinozaki, T. Yokoyama, and H. Nagawa, “Cytomegalovirus infection in ulcerative colitis,” Scandinavian Journal of Gastroenterology, vol. 41, no. 6, pp. 706–711, 2006. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  27. M. G. Revello and G. Gerna, “Diagnosis and management of human cytomegalovirus infection in the mother, fetus, and newborn infant,” Clinical Microbiology Reviews, vol. 15, no. 4, pp. 680–715, 2002. View at Publisher · View at Google Scholar
  28. B. Weber, A. Berger, and H. Rabenau, “Human cytomegalovirus infection: diagnostic potential of recombinant antigens for cytomegalovirus antibody detection,” Journal of Virological Methods, vol. 96, no. 2, pp. 157–170, 2001. View at Publisher · View at Google Scholar
  29. A. T. Rowshani, F. J. Bemelman, E. M. M. van Leeuwen, R. A. W. Van Lier, and I. J. M. Ten Berge, “Clinical and immunologic aspects of cytomegalovirus infection in solid organ transplant recipients,” Transplantation, vol. 79, no. 4, pp. 381–386, 2005. View at Publisher · View at Google Scholar
  30. G. Boivin, J. Handfield, E. Toma et al., “Evaluation of the AMPLICOR cytomegalovirus test with specimens from human immunodeficiency virus-infected subjects,” Journal of Clinical Microbiology, vol. 36, no. 9, pp. 2509–2513, 1998.
  31. T. Lazzarotto, G. T. Maine, P. Dal Monte, H. Frush, K. Shi, and M. P. Landini, “Detection of serum immunoglobulin M to human cytomegalovirus by Western blotting correlates better with virological data than detection by conventional enzyme immunoassay,” Clinical and Diagnostic Laboratory Immunology, vol. 3, no. 5, pp. 597–600, 1996.
  32. J. D. Meyers, P. Ljungman, and L. D. Fisher, “Cytomegalovirus excretion as a predictor of cytomegalovirus disease after marrow transplantation: importance of cytomegalovirus viremia,” Journal of Infectious Diseases, vol. 162, no. 2, pp. 373–380, 1990.
  33. A. Michaelides, L. Liolios, E. M. Glare et al., “Increased human cytomegalovirus (HCMV) DNA load in peripheral blood leukocytes after lung transplantation correlates with HCMV pneumonitis,” Transplantation, vol. 72, no. 1, pp. 141–147, 2001. View at Publisher · View at Google Scholar
  34. W. D. Rawlinson, “Broadsheet. Number 50: diagnosis of human cytomegalovirus infection and disease,” Pathology, vol. 31, no. 2, pp. 109–115, 1999.
  35. L. Beaugerie, C. Cywiner-Golenzer, L. Monfort et al., “Definition and diagnosis of cytomegalovirus colitis in patients infected by human immunodeficiency virus,” Journal of Acquired Immune Deficiency Syndromes and Human Retrovirology, vol. 14, no. 5, pp. 423–429, 1997.
  36. A. Kandiel and B. Lashner, “Cytomegalovirus colitis complicating inflammatory bowel disease,” American Journal of Gastroenterology, vol. 101, no. 12, pp. 2857–2865, 2006. View at Publisher · View at Google Scholar · View at PubMed
  37. M. M. Maher and M. I. Nassar, “Acute cytomegalovirus infection is a risk factor in refractory and complicated inflammatory bowel disease,” Digestive Diseases and Sciences, vol. 54, no. 11, pp. 2456–2462, 2009. View at Publisher · View at Google Scholar · View at PubMed
  38. V. Criscuoli, M. R. Rizzuto, and M. Cottone, “Cytomegalovirus and inflammatory bowel disease: is there a link?” World Journal of Gastroenterology, vol. 12, no. 30, pp. 4813–4818, 2006.
  39. K. Matsuoka, Y. Iwao, T. Mori et al., “Cytomegalovirus is frequently reactivated and disappears without antiviral agents in ulcerative colitis patients,” American Journal of Gastroenterology, vol. 102, no. 2, pp. 331–337, 2007. View at Publisher · View at Google Scholar · View at PubMed
  40. I. A. Eyre-Brook and S. Dundas, “Incidence and clinical significance of colonic cytomegalovirus infection in idiopathic inflammatory bowel disease requiring colectomy,” Gut, vol. 27, no. 12, pp. 1419–1425, 1986.
  41. M. Nguyen, K. Bradford, and X. Zhang, “Severity of cytomegalovirus infection on pathology specimens is associated with colectomy rates and response to antiviral therapy in inflammatory bowel disease patients,” Digestive Disease Week, vol. 2010, no. 445, 2010.